ciliobrevin A,
hedgehog pathway inhibitor-4,
HPI-4 compound,
Ciliobrevin A,
302803-72-1,
HPI-4,
(E)-3-(2,4-dichlorophenyl)-3-oxo-2-(4-oxo-3,4-dihydroquinazolin-2(1H)-ylidene)propanenitrile,
HPI-4 (Ciliobrevin A),
Hedgehog Pathway Inhibitor 4,
AC1OBPXG,
AC1OA85T,
CHEMBL3133042,
SCHEMBL11315337,
(2E)-3-(2,4-dichlorophenyl)-2-(4-hydroxyquinazolin-2(1H)-ylidene)-3-oxopropanenitrile,
(2E)-3-(2,4-dichlorophenyl)-3-oxo-2-(4-oxo-1H-quinazolin-2-ylidene)propanenitrile,
EX-A1976,
HPI-4,Hedgehog Pathway Inhibitor 4,
s8249,
AKOS030243148,
CS-6016,
HPI-4, >=98% (HPLC),
HY-100790,
A16349,
SR-01000429796,
J-017853,
SR-01000429796-1,
2,4-Dichloro-?-(3,4-4-oxo-2(1H)-quinazolinylidene)-?-oxobenzenepropanenitrile,
3-(2,4-dichlorophenyl)-3-oxo-2-(4-oxo-1H-quinazolin-2-ylidene)propanenitrile,
ZINC02311087,
CID6800657,
CID6883982,